Literature DB >> 23293796

Edmund Biernacki (1866-1911): Discoverer of the erythrocyte sedimentation rate. On the 100th anniversary of his death.

Andrzej Grzybowski1, Jarosław Sak.   

Abstract

In contemporary medicine, the erythrocyte sedimentation rate (ESR) is used to assess severity in patients with such diseases as erysipelas, psoriasis, eosinophilic fasciitis, dermatomyositis, and Behçet's disease. We remember the scientific achievements of a Polish physician, the discoverer of the erythrocyte sedimentation rate (ESR), Edmund Faustyn Biernacki (1866-1911), on the 100th anniversary of his death. The practical application of ESR in clinical diagnostics in 1897 by Biernacki was little known for many years, because it was often neglected owing to the work of Robert Fåhraeusand Alf Westergren from 1921. In addition, it is also frequently omitted that before Westergren's and Fåhraeus's reports were published, ESR was also noticed by Ludwig Hirschfeld in 1917.

Entities:  

Mesh:

Year:  2011        PMID: 23293796     DOI: 10.1016/j.clindermatol.2011.08.033

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  3 in total

1.  Sesquicentennial of the birth of Edmund Faustinus Biernacki, a discoverer of the erythrocyte sedimentation rate.

Authors:  Eugeniusz J Kucharz
Journal:  Reumatologia       Date:  2017-03-22

2.  National eponyms in medicine.

Authors:  Barbara Nieradko-Iwanicka
Journal:  Reumatologia       Date:  2020-02-28

3.  Novel characteristics of soluble fibrin: hypercoagulability and acceleration of blood sedimentation rate mediated by its generation of erythrocyte-linked fibers.

Authors:  Dennis K Galanakis; Anna Protopopova; Kao Li; Yingjie Yu; Tahmeena Ahmed; Lisa Senzel; Ryan Heslin; Mohamed Gouda; Jaseung Koo; John Weisel; Marilyn Manco-Johnson; Miriam Rafailovich
Journal:  Cell Tissue Res       Date:  2022-03-11       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.